Israel Today spoke with a research lab in Kiryat Shmonah, Israel’s northern frontier town on the border with Lebanon, that is now poised to be the first to develop a vaccine for the coronavirus afflicting the globe.
After 4 years of research funded by Israel’s Ministry of Science & Technology, researchers at MIGAL have developed an effective vaccine against avian coronavirus Infectious Bronchitis Virus (IBV), which can be adapted soon to create a human vaccine against the coronavirus COVID-19.
“Our goal is to produce the vaccine during the next 8-10 weeks, and to achieve safety approval in a few weeks. This will be an oral vaccine, making it particularly accessible to the general public. We are currently in intensive discussions with potential partners that can help accelerate the trial phase and expedite the final product’s development and regulatory activities. Given the urgent global need for a human coronavirus vaccine, we are doing everything we can to accelerate development,” said David Zigdon, CEO of the Institute for Scientific Research in the Galilee (MIGAL).
How did you...